Work

Neoadjuvant androgen deprivation therapy with enzalutamide plus the glucocorticoid receptor modulator relacorilant versus placebo for patients with high-risk localized prostate cancer.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.5_suppl.tps436

Authors: Mohammad O. Atiq, Walter Michael Stadler, Ashley Page, Meghan Catenacci, Akash Patnaik, Gladell P Paner, Scott Eggener, Russell Zelig Szmulewitz

Institution: University of Chicago

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407700608

Cites:

Cited by:

Related to: 10